This result is particularly striking given we had tissue from only 50 individuals, further analysis using a larger tissue microarray cohort would be beneficial to replicate these findings for dystrophin as an independent prognostic marker in HNSCC. The gene discussed is DMD; the disease is head and neck squamous cell carcinoma.